| Net Cash Provided by (Used in) Operating Activities |
$1,012,000,000 |
USD |
1346% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$14,274,000,000 |
USD |
-22% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$16,888,000,000 |
USD |
-3.1% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
90,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
580,389,090 |
shares |
2.6% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,599,000,000 |
USD |
-179% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$21,201,000,000 |
USD |
20% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$321,000,000 |
USD |
92% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$75,000,000 |
USD |
127% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$5,275,000,000 |
USD |
-50% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
28,749,665 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$10,000,000 |
USD |
-47% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$16,925,000,000 |
USD |
12% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
28,749,665 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$308,000,000 |
USD |
29% |
Q1 2025 |
Q1 2025 |
| Share-based Payment Arrangement, Expense |
$766,000,000 |
USD |
-28% |
Q3 2025 |
Q3 2025 |